Over the last few years, peroxisome proliferator-activated receptor γ (PPARγ), a nuclear receptor involved in adipogenesis, has received much attention in breast cancer tumorigenesis for its ability to exert anti-tumor effects through a dual action in breast cancer cells as well as in the components of the TME. This evidence concerns the gene PPARG and neoplasm.